Abstract
Introduction
Diabetic retinopathy (DR) is recognized as a significant complication of diabetes and continues to be a prominent contributor to global blindness. Epidemiological investigations have pinpointed various lifestyle risk factors accountable for the onset and progression of DR. However, pinpointing the most influential factors is challenging due to variability in ethnic background, study design, and sample size in previous research.
Methodology
In the present study, a systematic and comprehensive review was conducted to identify significant factors contributing to DR development. Following the PRISMA guidelines, 322 articles were screened, and six articles discussing various lifestyle factors were included.
Result
Elevated blood sugar levels (hyperglycemia), abnormal lipid profiles (dyslipidemia), high blood pressure (hypertension), and the duration of diabetes have been identified as the predominant lifestyle risk factors associated with the development and progression of DR. Furthermore, male gender was also linked to the occurrence of DR.
Conclusion
While gender is beyond control, the other identified factors associated with DR can be managed through improved eating habits and regular exercise. Future investigations should prioritize exploring the collective influence of these factors on the development and progression of DR.
Similar content being viewed by others
Data availability
No data was used for the research described in the article.
References
Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th edition. Curr Diabetes Rev. 2023.
International Diabetes Federation. Diabetes facts and figures. Available online: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed 9 Dec 2021.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Magliano DJ. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract, 2019;157, 107843.
Mrugacz M, Bryl A, Zorena K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med. 2021;10:458.
Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44:260–77.
Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.
UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Bri Med J. 1998;317:703–13.
Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.
Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25.
Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci. 2003;44(12):5327–34.
Li W, Liu X, Yanoff M, Cohen S, Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia. 1996;39:537–47.
Perrott RL, North RV, Drasdo N, Ahmed KA, Owens DR. The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus. Diabetologia. 2001;44:700–5.
Fort PE, Losiewicz MK, Reiter CE, Singh RS, Nakamura M, Abcouwer SF, Barber AJ, Gardner TW. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance. PloS one. 2011;6(10):e26498.
Ahmed KR, Karim MN, Bhowmik B, Habib SH, Bukht MS, Ali L, Hussain A. Incidence of diabetic retinopathy in Bangladesh: a 15-year follow-up study. J Diabetes. 2012;4(4):386–91.
Foo V, Quah J, Cheung G, Tan NC, Ma Zar KL, Chan CM, Lamoureux E, Tien Yin W, Tan G, Sabanayagam C. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes. 2017;9(2):200–7.
Moh A, Neelam K, Zhang X, Sum CF, Tavintharan S, Ang K, Lee SBM, Tang WE, Lim SC. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes. Endocr Res. 2018;43(3):186–94.
Yuan J, Zhang L, Jia P, Xin Z, Yang JK. Early onset age increased the risk of diabetic retinopathy in type 2 diabetes patients with duration of 10–20 years and HbA1C ≥7%: a hospital-based case-control study. Int J Endocrinol. 2021;10(2021):5539654.
Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92.
Susarla G, Rizza AN, Li A, Han S, Khan R, Chan W, Sobrin L. Younger age and albuminuria are associated with proliferative diabetic retinopathy and diabetic macular edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study. Curr Eye Res. 2022;47(10):1416–23.
Wild S, Roglic G, Green A, Sicree R, King H. Lobal prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.
Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian J Ophthalmol. 2009;57(4):293–8.
Liu L, Wu J, Yue S, Geng J, Lian J, Teng W, Huang D, Chen L. Incidence density and risk factors of diabetic retinopathy within type 2 diabetes: a five-year cohort study in China (report 1). Int J Environ Res Public Health. 2015;12(7):7899–909.
Yoshida Y, Hagura R, Hara Y, Sugasawa G, Akanuma Y. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes Res Clin Pract. 2001;51:195–203.
Klein R, Klein BE, Moss SE, Cruickshanks KJ. The wisconsin epidemiologic study of diabetic retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112(9):1217–28.
Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, Klein R. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes. 1988;37(7):878–84.
Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes. 1989;38(4):435–40.
Namperumalsamy P, Kim R, Vignesh TP, Nithya N, Royes J, Gijo T, Vijayakumar V. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Postgrad Med J. 2009;85(1010):643–8.
Sikka R, Raina P, Soni R, Gupta H, Bhanwer AJS. Genomic profile of diabetic retinopathy in a north Indian cohort. Mol Biol Rep. 2023;50:1–10.
Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report# 18. Invest Ophthalmol Visual Sci. 1998;39:233–52.
Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Arrieta-Blanco FJ, Gomez-Campelo P, MADIABETES Group. Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One, 2013;8(10), e76417
WHO. Hypertension. 2023. https://www.who.int/news-room/fact-sheets/detail/hypertension.
Snow V, Weiss KB, Mottur-Pilson C. Clinical Efficacy Assessment Subcommittee of the American College of Physicians*. The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Annals Internal Med, 2003;138(7), 587-592.
United Kingdom Prospective Diabetes Study Group.UK Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of type 2 diabetes and associated risk factors. Arch Ophthalmol 1998; 116:297–303.
Landmesser ULF, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. In Semin Thromb Hemost. 2000;26:529–38.
Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol-Heart Circ Physiol. 1997;273:H2442-51.
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Ethical approval
Not applicable.
Competing interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Upadhayay, P., Singh, N., Pandey, M. et al. Unveiling the link between lifestyle risk factors and diabetic retinopathy. Int J Diabetes Dev Ctries (2024). https://doi.org/10.1007/s13410-024-01332-6
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13410-024-01332-6